New Jersey's diversion framework is spread across four places. The Comprehensive Drug Reform Act's criminal offences are in Title 2C, chapter 35 of the statutes. Professional discipline for every licensed profession, pharmacists included, runs through the Uniform Enforcement Act in Title 45, chapter 1. The Division of Consumer Affairs, through its Drug Control Unit, makes the controlled-dangerous-substance registration rules in N.J.A.C. 13:45H, which hold the security and theft-reporting duties. The Division's Prescription Monitoring Program rules in N.J.A.C. 13:45A-35 hold the dispensing-data duties. The State Board of Pharmacy's own rules are in N.J.A.C. 13:39 and this page does not restate them. Each statement below links to the text it comes from.

Statutes: the fraud offence and the Uniform Enforcement Act

The offence closest to prescription-drug diversion by deceit is obtaining a controlled dangerous substance by fraud, N.J.S.A. 2C:35-13. The statute provides in pertinent part that it is unlawful for any person to acquire or obtain possession of a controlled dangerous substance by misrepresentation, fraud, forgery, deception or subterfuge [1]. The State's model jury charge lists three elements the State must prove beyond a reasonable doubt: that the defendant acquired or obtained possession of a controlled dangerous substance, that the defendant did so by misrepresentation, fraud, forgery, deception or subterfuge, and that the defendant acted knowingly [1].

The charge also defines the terms in a way that matters to records-based cases. Forgery includes the intentional and unauthorised alteration, creation, completion or issuance of any writing, and deception includes the failure to correct a false impression that was previously created or reinforced [1].

Licence discipline is separate. Section 8 of P.L. 1978, c. 73 (N.J.S.A. 45:1-21) lets a board refuse to issue, suspend or revoke a licence on proof of any of a list of grounds. As reprinted in P.L. 2021, c. 81, they include dishonesty, fraud or deception; gross negligence, or repeated acts of negligence; professional misconduct as the board determines; conviction of, or engaging in acts constituting, any crime that has a direct or substantial relationship to the regulated activity; violation of or failure to comply with any act or regulation the board administers; and prescribing or dispensing controlled dangerous substances indiscriminately or without good cause, or where the holder knew or should have known they were to be used for unauthorised consumption or distribution [2].

Rules: security and the registrant's duties

Under N.J.A.C. 13:45H-2.5, controlled substances listed in Schedule I must be stored in a securely locked, substantially constructed cabinet. Schedules II to V must also be in a securely locked, substantially constructed cabinet, but pharmacies may disperse them throughout the stock of noncontrolled substances in such a manner as to obstruct the theft or diversion of the controlled substances [3]. The same section bars a registrant from employing, as an agent or employee who has access to controlled substances, any person who has had an application for registration denied, or a registration revoked, at any time [3].

Rule 13:45H-2.4 sets the distribution-side duties. Before distributing a controlled substance to a person the registrant does not know to be registered, the registrant must make a good faith inquiry with the Drug Control Unit. The registrant must also design and operate a system to disclose suspicious orders, and inform the Unit of suspicious orders when discovered; suspicious orders include orders of unusual size, orders deviating substantially from a normal pattern, and orders of unusual frequency [4].

Penalties: criminal, licence and civil

This page does not state a sentence or fine for obtaining a controlled dangerous substance by fraud. The sources that could be opened for this review, the model jury charge and the Uniform Enforcement Act reprint, set out the elements and the grounds but not the sentencing grade, and the official statute text of N.J.S.A. 2C:35-13 could not be retrieved in a form that could be checked. Anyone relying on a penalty should read those sections directly on the Legislature's site.

What can be stated from the sources is the range of licence consequences. Under N.J.S.A. 45:1-21 a board may refuse to admit a person to an examination, refuse to issue a licence, or suspend or revoke a certificate, registration or licence [2]. A plea of guilty, non vult, nolo contendere or any other disposition of alleged criminal activity is deemed a conviction for the crime ground [2]. The same reprint adds a safeguard: a licensing entity may not disqualify a person solely because of a conviction unless the offence has a direct or substantial relationship to the regulated activity or the licence would be inconsistent with the public's health, safety or welfare, and it must consider the seriousness of the offence, the time since it, evidence of rehabilitation, and the offence's relationship to the fitness the profession requires [2].

Reporting duties and deadlines

New Jersey's theft rule is short and unconditional. Under N.J.A.C. 13:45H-2.4(c), the registrant shall notify the Drug Control Unit of any theft or loss of any controlled substances upon discovery, and shall also complete the DDC-52 form regarding the theft or loss. Thefts must be reported whether or not the controlled substances are subsequently recovered and whether or not the responsible parties are identified and action taken against them [4]. Rule 13:45H-2.5(d), which covers practitioners and pharmacies, repeats the notify-upon-discovery duty and the DDC-52 form [3]. The rule text read for this page sets no number of days; it says upon discovery.

Lost or stolen order forms have their own rule. Under N.J.A.C. 13:45H-6.6(b), a purchaser or supplier that has used or unused order forms stolen or lost, other than in transmission, must comply with 21 C.F.R. 1305.16 and, immediately on discovery, report the theft or loss to the Drug Control Unit. If an unused form reported lost is later found, the Unit must be notified immediately [5]. The federal DEA Form 106 requirement is outside the scope of this page.

Dispensing data is reported on a daily basis. Under N.J.A.C. 13:45A-35.3(a), a pharmacy filling a prescription for a Schedule II, III, IV or V controlled dangerous substance, for human growth hormone or for gabapentin in an outpatient setting must collect and electronically transmit to the Division's vendor, on a daily basis, information for each prescription, including the patient's name and date of birth, the date dispensed, the prescription number and National Drug Code, the pharmacy permit number, the prescriber's name and DEA number, the drug, strength and quantity, the date issued and the source of payment [6].

Monitoring: the Prescription Monitoring Program

The Prescription Monitoring Program in the Division of Consumer Affairs implements P.L. 2007, c. 244, as amended, codified at N.J.S.A. 45:1-44 through 51. Its rules apply to pharmacies filling outpatient prescriptions for the listed substances, to out-of-state pharmacies registered with the Board of Pharmacy that ship into New Jersey, and to pharmacists employed by a current permit holder [7]. Reporting does not apply to the direct administration of a controlled substance to an ultimate user, or to prescriptions dispensed to an inpatient at a hospital, long-term care or other facility with 24-hour nursing care [7].

The pharmacist's look-up duty is conditional. Under N.J.A.C. 13:45A-35.9(b), if the pharmacist has a reasonable belief that the person may be seeking a controlled dangerous substance for any purpose other than the treatment of an existing medical condition, such as misuse, abuse or diversion, the pharmacist shall not dispense a Schedule II substance, any opioid, or a Schedule III or IV benzodiazepine without first accessing the monitoring information to determine whether the person has received other prescriptions that indicate misuse, abuse or diversion [8]. The data rule adds a related duty: identifying information for any individual other than the patient who picks up the prescription must be transmitted if the pharmacist reasonably believes the pickup may be for a purpose other than delivering the drug to the patient [6].

For impaired licensees, the Uniform Enforcement Act ground is that the holder is presently engaged in drug or alcohol use that is likely to impair the ability to practise with reasonable skill and safety, where presently means at this time or at any time within the previous 365 days. A separate ground covers a holder incapable, for medical or any other good cause, of discharging the functions of a licensee consistently with public health and safety [2]. The sources read do not describe a monitoring or treatment programme for pharmacists, so none is described here.

Sources

Each link below was fetched on 15 November 2026 and returned HTTP 200. Bracketed numbers in the text open the same pages.

  1. New Jersey Model Criminal Jury Charge: Obtaining a Controlled Dangerous Substance by Fraud (N.J.S.A. 2C:35-13), approved 10/17/88
  2. P.L. 2021, c. 81 (S942 2R), amending section 8 of P.L. 1978, c. 73 (N.J.S.A. 45:1-21)
  3. N.J.A.C. 13:45H-2.5, Physical security controls for practitioners (Cornell LII)
  4. N.J.A.C. 13:45H-2.4, Other security controls for nonpractitioners (Cornell LII)
  5. N.J.A.C. 13:45H-6.6, Lost and stolen order forms (Cornell LII)
  6. N.J.A.C. 13:45A-35.3, Pharmacy reporting requirements; electronic format (Cornell LII)
  7. N.J.A.C. 13:45A-35.1, Purpose and scope (Cornell LII)
  8. N.J.A.C. 13:45A-35.9, Mandatory look-up (Cornell LII)

Scope. This page summarises statutes and rules as read in November 2026 and is not legal advice. The Uniform Enforcement Act text is from the Second Reprint of P.L. 2021, c. 81 and may have been amended since; the Administrative Code text was read on Cornell's Legal Information Institute copy of N.J.A.C. rather than the State's own. The official Legislature and Division pages were not retrievable in checkable form, which is why the criminal sentencing grade and the civil penalty amounts are not stated. The page does not cover N.J.A.C. 13:39, federal DEA requirements, or amendments made after the versions read. Check the current text and the Division's guidance before relying on a deadline or penalty.

Related pages

Would your controls meet these duties?

The free self-assessment scores your own controls: 7 sections, 45 weighted items, a score for each section, and a PDF you can take to your committee. No account or login.

Start the free assessment

Would your controls meet these duties?

The free self-assessment scores your own controls: 7 sections, 45 weighted items, a score for each section, and a PDF you can take to your committee. No account or login.

Start the free assessment